If a patient runs out of Wellbutrin (bupropion) and stops taking it for 14 days, can they resume the previous dose?

Restarting Wellbutrin After 14-Day Interruption

After a 14-day interruption of Wellbutrin (bupropion), patients should NOT resume at their previous dose but must restart with dose titration beginning at 150 mg once daily, as the drug has been completely eliminated from the body and steady-state concentrations are lost.

Rationale for Dose Retitration

Pharmacokinetic Considerations

• Bupropion has a half-life of approximately 21 hours, and its active metabolite hydroxybupropion has a half-life of approximately 20 hours 1
• After 14 days (approximately 16 half-lives), the drug and its metabolites are completely eliminated from the body 1
• Steady-state concentrations, which take at least 5 half-lives to achieve, are entirely lost after this duration 1

FDA-Mandated Titration Schedule

The FDA drug label explicitly requires gradual dose escalation to minimize seizure risk 2:

• Start at 150 mg once daily in the morning
• After 4 days, may increase to target dose of 300 mg once daily (for major depressive disorder) 2
• This titration schedule must be followed to minimize the risk of seizures, which is dose-dependent and increases with abrupt dose escalation 2

Critical Safety Concerns

Seizure Risk

• Bupropion is contraindicated in patients with seizure disorders due to dose-dependent seizure risk 2
• The seizure threshold is lowered when doses are escalated too rapidly or when higher doses are reintroduced without titration 3, 4
• Studies show seizures occurred in 0.8% of patients who inadvertently took extra doses, which is twice the rate seen with therapeutic dosing 3
• Maximum daily dose should not exceed 300 mg when using extended-release formulations 5

Adverse Effects Without Titration

When patients take extra doses or restart at higher doses without titration 3:

• Agitation (8.2% of cases)
• Dizziness (7.4%)
• Tremor (7.1%)
• Nausea/vomiting (6.7%)
• Tachycardia (5.5%)
• Overall, 38.4% experienced at least one adverse effect with extra dosing 3

Clinical Algorithm for Restarting

Step 1: Assess Duration of Interruption

• If interruption ≥14 days: Full retitration required (as drug is completely eliminated)
• If interruption <14 days: Consider partial retitration based on clinical judgment, though specific guidance is limited in the literature

Step 2: Restart Protocol

1. Begin with 150 mg once daily in the morning 2
2. Wait minimum 4 days before dose escalation 2
3. Increase to 300 mg once daily if previously tolerated and clinically indicated 2
4. Administer in the morning to minimize insomnia risk 2

Step 3: Monitor for Adverse Effects

• Assess for neuropsychiatric symptoms including depression worsening, suicidal ideation, agitation, or unusual behavioral changes 5
• Monitor for seizure precursors: tremor, agitation, confusion 3, 4
• Evaluate tolerability before each dose escalation 2

Common Pitfalls to Avoid

Do NOT Resume at Previous Dose

• Restarting at 300 mg after 14 days off medication bypasses the required titration and significantly increases seizure risk 2, 3
• The body has no residual drug levels to provide tolerance to higher doses 1

Do NOT Confuse with Continuation Therapy

• The NCCN guidelines stating patients "may continue or resume initial pharmacotherapy" refer to patients who continue smoking during treatment, NOT patients who have stopped medication entirely 5
• This guidance applies to smoking cessation contexts where medication adherence is being addressed, not medication interruption 5

Do NOT Assume All Antidepressants Are the Same

• Unlike some SSRIs, bupropion has specific seizure risks that mandate careful dose titration 2, 4
• The dopamine/norepinephrine mechanism differs from serotonergic antidepressants and requires different safety considerations 5, 6

Special Populations Requiring Extra Caution

Patients with Increased Seizure Risk

Bupropion is contraindicated in 2:

• History of seizure disorder
• Current or prior bulimia or anorexia nervosa
• Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs
• Brain metastases or stroke history 5

Hepatic or Renal Impairment

• Moderate to severe hepatic impairment: Maximum 150 mg every other day 2
• Renal impairment (GFR <90 mL/min): Consider reduced dose and/or frequency 2
• These patients require even more cautious retitration due to altered drug clearance 2